BTG3 and hepatocellular carcinoma: The down- regulated expression of BTG3 is documented in ovarian, lung, prostate or renal, hepatocellular cancer tissues or cells, and its expression is restored by the treatment with genistein and 5-aza-2′- deoxycytidine [6, 15-19].